Coalesenz Inc.
Cambridge, MA
- UEI
- J2FNAFKMP664
- CAGE
- 8C2V5
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 459 Concord Ave, Cambridge, MA 02138, USA
- Website
- coalesenz.com
- Founded
- 2020
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- SIC code
- 38 Instruments & Related Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $549,959 |
Contract awards
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Multifunctional coagulation and platelet profiling during cardiaccirculatory support | National Heart Lung and Blood Institute (NIH) | $95,915 |
Similar vendors
About the company
Coalesenz Inc. is a self-certified Small Disadvantaged Business and Woman Owned Small Business that specializes in developing innovative medical technologies, particularly in the field of hemostasis and coagulation diagnostics. The company, registered with SAM.gov since May 2019, has received both federal contract and grant awards for its research and development efforts. Coalesenz Inc. focuses on creating point-of-care diagnostic tools for blood coagulopathy, which have potential applications in combat casualty care and mechanical circulatory support scenarios.
Coalesenz Inc. has been awarded two notable federal contracts in recent years, both related to its work on blood coagulopathy diagnostics. In December 2019, the company received a $162,500 Small Business Technology Transfer (STTR) Phase I purchase order from the Defense Health Agency for developing point-of-care blood coagulopathy diagnostics. This was followed by a more substantial STTR Phase II contract in September 2020, awarded by the Department of the Army Medical Command. Valued at $1,099,955.02, this contract focuses on advancing the Combat Casualty Care Research Program (CCCRP) through the development of point-of-care blood coagulopathy diagnostics. Both contracts were set aside for total small business participation, aligning with Coalesenz Inc.'s status as a small disadvantaged, woman-owned small business.
In addition to its contract work, Coalesenz Inc. has also secured a significant federal grant award. The company received a project grant from the National Heart Lung and Blood Institute, set to begin on May 1, 2024, and conclude on April 30, 2025. This grant supports the development of a multifunctional coagulation and platelet profiling system for use during cardiac circulatory support. The project aims to advance a novel, hand-sized hemostasis profiler called iCoagLab, designed to serve as a companion diagnostic during mechanical circulatory support (MCS) to predict potentially lethal bleeding in patients. This research addresses a critical need in managing complex cardiac conditions and could significantly improve patient outcomes by enabling rapid, comprehensive assessment of coagulation at the point-of-care.
Quick answers
Is Coalesenz Inc. registered in SAM.gov?
Yes. Coalesenz Inc.'s SAM.gov registration is active through March 5, 2027.
How much has Coalesenz Inc. received in federal contracts?
Federal contracts obligated $549,959 to Coalesenz Inc. in fiscal year 2025.
What is Coalesenz Inc.'s most recent federal award?
Coalesenz Inc.'s most recent federal contract award is Award a research and development small business technology transfer program phase II enhancement award to coalesenz… (HT942525CE002), from Defense Health Agency, on July 28, 2025.
On GovTribe
See Coalesenz Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors